Braskem (BAK) Q4 2025 earnings review

Surviving the Trough: Heavy Write-Downs and Soaring Leverage

Braskem is fighting a brutal petrochemical downcycle with drastic measures. While 4Q25 Recurring EBITDA stabilized at US$109M (+7% YoY), the bottom line was crushed by a US$1.4B non-cash deferred tax write-off and a US$272M impairment at Braskem Idesa. Corporate leverage has ballooned to a highly concerning 14.74x. With Braskem Idesa defaulting on its debt and facing potential Chapter 11, the company is leaning on Brazilian tariff protections and potential Middle East supply disruptions to flip the pricing script in 2026.

๐Ÿ‚ Bull Case

Macro Supply Shock

The Strait of Hormuz conflict could restrict 4-11% of global PE supply. As an Americas-based producer, Braskem is positioned to capture significant margin upside if Middle East exports are disrupted.

Domestic Protections

Brazil's preservation of the 20% import tariff on resins and the approval of the PRESIQ tax framework give Braskem a shielded, highly profitable domestic baseline against global dumping.

๐Ÿป Bear Case

Debt Crisis at Braskem Idesa

Braskem Idesa has defaulted on 2029 and 2032 notes, with credit ratings slashed to 'D' and 'RD'. Restructuring (potentially via Chapter 11) introduces massive uncertainty regarding control and future cash flows.

Crushing Leverage

Corporate leverage sits at 14.74x. While management drew down a $1B standby facility to pad liquidity, the debt load leaves zero room for execution errors if the petrochemical cycle remains depressed.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. The potential macro upside from Middle East disruptions is heavily outweighed by distress at Braskem Idesa, extreme consolidated leverage, and the structural reliance on regulatory tariffs to defend margins.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Braskem Idesa Collapse and Restructuring

The situation in Mexico is critical. Braskem Idesa missed interest payments on its 2029 and 2032 bonds, triggering downgrades to 'D' by S&P and 'RD' by Fitch. The segment recognized a US$272M impairment in 4Q25. Management is actively evaluating Chapter 11 reorganization, which could alter Braskem's shareholding control of the asset.

DRIVERNEWโšช

Strait of Hormuz Supply Shock

Geopolitical tensions in the Middle East present a major upside catalyst. Management models that a logistical restriction in the Strait of Hormuz could cut global PE supply by 6-19 million tons (4-11% of global operating rates). While short-term naphtha costs will spike, Americas producers would gain massive pricing power to offset it.

DRIVER๐ŸŸข

Regulatory Moat: PRESIQ and Tariffs

Government intervention is actively subsidizing margins. The extension of the 20% import tariff on PE, PP, and PVC insulates Braskem from cheap Asian/US dumping. Additionally, the new PRESIQ framework (effective 2027) and REIQ benefits directly lower feedstock tax burdens, acting as a direct margin buffer.

CONCERN๐Ÿ”ด

US and Europe Segment Bleeding

The US and Europe segment was the primary laggard, posting a negative US$32M EBITDA in 4Q25. PP spreads in Europe collapsed 33% QoQ due to a surge in imported supply. Utilization rates fell 800 basis points to 71% due to scheduled shutdowns and aggressive inventory optimization.

DRIVER๐ŸŸข

Transforma Rio and Feedstock Flexibility

Braskem is executing its strategy to cut naphtha dependency from 80% to 60% by 2030. The 'Transforma Rio' project (R$4.2 billion investment) will add 220kt of gas-based ethylene capacity. Concurrently, Plant 1 in Bahia is transitioning from naphtha to ethanol, permanently shifting the cost curve.

CONCERNNEW๐Ÿ”ด

Naphtha Price Lag Squeeze

Oil price volatility driven by the Middle East conflict immediately spikes naphtha costs (Braskem's primary feedstock). Management noted a timing mismatch: raw material costs hit the P&L immediately via COGS, but resin price increases take 1-2 months to catch up, consuming working capital in the interim.

Other KPIs

Alagoas Provision BalanceR$ 3.50 billion

Stable. The provision balance declined slightly from R$3.78B in 3Q25, driven by R$318M in payments. Relocation is effectively complete (99.9%), but technical filling of salt cavities and socio-urban remediation will require steady cash outflows over the coming years.

Consolidated Net Loss-US$ 1.88 billion

Reversing heavily downward. The massive loss in 4Q25 was not primarily operational, but driven by a US$1.4 billion write-off of deferred tax assets (CPC 32 accounting rules) due to the prolonged timeline for profitability, plus the US$272 million Braskem Idesa impairment.

Green Ethylene Utilization67%

Accelerating from 40% in 3Q25 following the completion of inventory optimization. Green PE sales volumes rose 18% QoQ, driven by strong pre-Lunar New Year demand in Asia.

Guidance

2026 Operational & Strategic InvestmentsUS$ 465 million

Accelerating slightly vs the US$ 434 million actual spend in 2025 (excluding Braskem Idesa and REIQ investments). The focus is on Rio Grande do Sul maintenance and the early stages of the Transforma Rio gas-expansion project.

Q1 2026 Petrochemical Spreads+50% vs 4Q25

Accelerating. While management avoids formal guidance, they explicitly cited external consultants projecting that Q1 spreads will rebound roughly 50% from Q4 levels, aligning back with historical averages.

Key Questions

Braskem Idesa Ring-Fencing

If Braskem Idesa proceeds with a Chapter 11 filing, what are the specific cross-default triggers or contagion risks to the parent company's balance sheet?

Naphtha Squeeze Duration

Given the recent spike in naphtha prices, how many months of severe margin compression are you modeling before resin price hikes fully offset the higher feedstock costs?

Deleveraging Timeline

With leverage at nearly 15x, what specific asset monetization or structural actions are actively being evaluated to protect the company's liquidity if the expected 2026 spread recovery is delayed?

Transforma Rio Financing

You mentioned the R$4.2 billion Transforma Rio project requires supplementary financing. At 14.74x leverage, how do you plan to secure this capital without further straining the balance sheet?